Macrolides and host defences to respiratory tract pathogens
- 1 September 1991
- journal article
- review article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 19, 11-19
- https://doi.org/10.1016/0195-6701(91)90213-r
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neotrophilsJournal of Antimicrobial Chemotherapy, 1989
- In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infectionAntimicrobial Agents and Chemotherapy, 1989
- An in-vitro evaluation of the cellular uptake and infraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agentJournal of Antimicrobial Chemotherapy, 1988
- An in Vitro Investigation of the Intracellular Bioactivity of Amoxicillin, Clindamycin, and Erythromycin for Staphylococcus aureusThe Journal of Infectious Diseases, 1986
- Effects of Erythromycin, Josamycin and Spiramycin on Rat Polymorphonuclear Leukocyte ChemotaxisChemotherapy, 1986
- Erythromycin Uptake and Accumulation by Human Polymorphonuclear Leukocytes and Efficacy of Erythromycin in Killing Ingested Legionella pneumophilaThe Journal of Infectious Diseases, 1984
- Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin.Journal of Clinical Investigation, 1983
- Antibiotic entry into human polymorphonuclear leukocytesAntimicrobial Agents and Chemotherapy, 1982
- A rapid micro method for the simultaneous determination of phagocytic-microbiocidal activity of human peripheral blood leukocytes in vitroJournal of Immunological Methods, 1977
- Killing of Intraleukocytie Staphylococcus aureus by Rifampin: In-Vitro and In-Vivo StudiesThe Journal of Infectious Diseases, 1972